- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 8.85M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 8.7M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 5.83M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$596.3K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.28M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $301.31K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $459.17K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$1.78M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$1.49M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.75M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$4.1M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.48M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.11M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.48M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.11M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $706.12K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $619.16K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $706.12K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $619.16K |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.13 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $0.10 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.13 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.10 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $978.58K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $788.33K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $165.58K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $62.13K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.15M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$603.08K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.14M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$850.46K |